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Abstract 
Whole blood contains all the elements that are necessary for oxygen delivery and hemostasis, in nearly 
physiologic ratios and concentrations. Transfusion therapy is a major resource that can improve the patient's 
capability to overcome the underlying disease. As veterinary critical care becomes more frequently used, the 
advantages of a basic knowledge of transfusion therapy and blood banking increased. The most cogent 
argument supporting component therapy is that blood is a precious resource considering its therapeutic 
potential and the logistics and costs required in obtaining and delivering blood products. The objective of 
this article is to discuss and offer current knowledge on blood transfusion and its allied practices in dogs 
including blood donor screening, blood typing, storing blood and crossmatching tests. The article discuses 
new developments, standard practices and protocols for conventional blood product collection in a private 
veterinary clinic. 
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Introduction 
The first documented transfusion in any species occurred in 1665 when Richard Lower 
withdrew blood from one dog and replaced it with blood from another dog. However, it was not 
until the 1950s that the use of transfusion medicine became more prominent in veterinary medicine 
because of the availability of equipment and techniques. 
A blood or blood component transfusion generally is a life-saving measure, but absolute 
safety can never be guaranteed. Although potentially life-saving, this procedure does carry some 
inherent risk. In addition to immune-mediated reactions caused by infusion of allogeneic cells or 
proteins, blood-borne pathogens can be transmitted by transfusion, potentially causing disease in 
the transfused recipient. To practice successful transfusion medicine, the veterinary doctor must 
understand not only when and how to administer the appropriate blood product; but also how to 
collect and store these products to minimize the potential for an adverse outcome. Also, in an effort 
to minimize pathogen transmission, all blood donors should be appropriately screened for 
infectious agents. Availability of expanded donor screening, typing modalities, and crossmatching 
techniques make choosing the right donor unit for each patient potentially more complicated. 
Firstly, blood is not ‘just another fluid’, but a complex, physiologically balanced, 
biological mixture. An understanding of its content is important when considering administering 
transfusions. All blood donors should be given thorough physical examinations at each donation 
and be annually screened haematologically, biochemically, and serologically. Donors should be 
healthy, receiving adequate nutrition, and be parasite free. All donors should be blood typed and 
be current on appropriate vaccinations. Female donors should not have had pups or kittens and 
preferably not be intact. 
 
Selection of donors. To be accepted into the donation program, the dog must meet the 
following eligibility criteria: 
1. The donor is between 1 and 8 years’ old 
2. The donor weight is over 25 kg 





4. The donor is docile and cooperative 
5. The donor has never benefited from transfusion therapy 
6. The donor does not suffer from chronic conditions 
7. The donor has no heart problems 
8. The donor is not currently receiving antibiotic treatment 
9. The donor has never suffered from Babesiosis 
10. The donor is not a carrier of blood-borne diseases 
Donation procedure implies harvesting from the jugular vein, monitoring the amount of 
blood collected on a scale, hermetically seal the bags using the dmachT sealant. 
 
Fig. 1. Monitoring the amount of blood collected 
 
Haematological and biochemical analisys 
For safety of both the blood donor and recipient, the health of a dog is evaluated prior to 
enrollment as a donor and then annually through a complete medical history, physical examination 
and laboratory evaluation including a hemogram and serum biochemistry profile. The following 
selection criteria were used to include dogs as blood donors: values of complete blood count (CBC) 
and serum biochemical profile (SBP) (total protein, albumin, urea, alkaline phosphatase, and 
alanine aminotransferase). In addition, a brief history, physical examination and measurement of 
packed cell volume (PCV) and haemoglobin (Hgb) concentration is performed prior to each blood 
donation. Donor PCV and HGB concentration should be at least 40% or 13g/dL, respectively. 
 
General principles of blood group testing 
Blood group testing can be performed in the clinic to screen potential dog blood donors and to 
type the recipient for appropriate donor selection prior to crossmatch and transfusion. To perform 
the test, 10 µl of whole blood collected on EDTA is required. Using a pipette, place the appropriate 
amount of blood into a clean tube, without additives and add 3 drops from the kit buffer. The 
solution is homogenized, then the strip is placed. After 2-4 minutes the migration is completed and 






Fig. 2. Determination of the DEA 1 group using the Alvedia kit 
 
There are eight commonly identified canine blood types. Because some DEA types are not 
very prevalent or do not stimulate a strong immune response, blood typing is generally limited to 
DEA 1.1 and 1.2. Dogs are believed to lack clinically relevant, naturally occurring antibodies 
against foreign erythrocyte antigens called alloantibodies. A first-time transfusion between two 
untyped dogs is unlikely to incite an acute transfusion reaction, even if they have different blood 
types. Despite the identification of many DEAs in dogs, the DEA 1 blood group is the most 
clinically important. In dogs that are DEA 1 negative, naturally occurring isohemaglutinins 
(antibodies) do not exist. However, transfusion of DEA 1 positive RBCs to a DEA 1 negative dog 
will result in rapid sensitization and anti-DEA 1 antibody production. Thereafter, a dog with anti- 
DEA 1 antibodies that subsequently receives a DEA 1 positive RBC transfusion can have a fatal 
hemolytic transfusion reaction. It is for this reason that all dogs requiring a transfusion should be 
blood typed prior to the transfusion of any blood components containing RBCs. Canine blood 
donors must be typed for DEA 1 at minimum because the practice of transfusing untyped canine 
RBCs is not considered acceptable or safe. Extended DEA typing of canine donors is controversial 
and must be performed through a commercial laboratory. 
 
Pathogen testing 
Pathogens for which testing is recommended met at least three of the following criteria: 
(1) the pathogen has been documented to cause clinical infection in recipients after blood 
transmission, (2) the pathogen is capable of causing subclinical infection such that carriers might 
inadvertently be identified as healthy blood donors, (3) the pathogen can be detected using culture 
or molecular methods from the blood of an infected animal, and (4) the resultant infection in the 
recipient has the potential to cause life-threatening illness and be difficult to eliminate with 
antimicrobial drugs. When screening for bloodborne pathogens in a potential blood donor, the test 
or tests with the greatest analytical sensitivity should be used. However, in situations where the 
prevalence of infection is low (as is the case for some pathogens in healthy animals compared with 
sick animals), positive results are more likely to represent false positives than in regions of high 
prevalence (low positive predictive value), and consideration should be given to verifying such 
positive results with a second test. 
Identification of parasites on blood smears. Blood parasites are organisms that live in the 
blood of their animal hosts. These parasites can range from single-celled protozoa to more complex 





they are transmitted through the bites of ticks or flies. The sample (EDTA anticoagulated blood) 
was kept at room temperature, well-mixed, clot free. Quick Romanowsky type stains (such as Diff- 
Quik) are modified versions that are inexpensive, robust, fast and easy to use and generally give 
very good results. Dogs are known to be infected by different haemoparasites viz. Babesia spp, 
Trypanosoma spp, Leishmania spp, Hepatozoon spp, Ehrlichia spp, Anaplasma spp, Mycoplasma 
spp (Haemobartonella) and Dirofilaria sp which are transmitted through different arthropod 
vectors like ticks, lice, triatomines, mosquitoes, tabanids and phlebotomine sand flies and produce 
illness collectively termed as canine vector borne diseases. 
 
Fig. 3. Babesia spp.pear shaped merozoites in pairs, 400x 
 
Microfilarial detection. One ml of blood in ethylene diamine tetraacetic acid (EDTA) was 
tested by standard filtration test and staining (methylene Blue-Giemsa). The number of 
microfilariae per millilitre (mf/ml) was calculated as the average of ten counts serially performed 
on 10 μl of blood samples. The identification of microfilariae was based on their morphology and 
morphometry. 
 
Fig. 4. Presence of microfilaria in blood smear examined on optical microscope. 400× 
 
Vector borne pathogens detection. The 4Dx snap test (IDEXX) in the veterinary world is 





process for six vector-borne diseases: heartworm, Lyme, Ehrlichia canis, Ehrlichia ewingi, 
Anaplasma phagocytophilum and Anaplasma platys. 
 
Fig. 5. Preparation of 4Dx snap test (IDEXX) 
 
The Crossmatch test 
Crossmatching reveals the presence of naturally occurring isoantibodies or antibodies 
generated in response to a previous incompatible transfusion. Crossmatching does not prevent 
sensitization of the patient to future transfusions. In fact, even though a specific blood donor is 
crossmatch compatible with the patient, if five or more days have elapsed since the first transfusion, 
another crossmatch must be performed if more blood products are to be administered and especially 









Fig. 6. Major crossmatch. A. incompatible cross-match; B. compatible cross-match 
Crossmatching is a simple technique that can be performed with standard laboratory equipment. 
The major crossmatch should always be compatible at room temperature and at 37 degrees Celsius 





grouping, and clerical errors in patient identification and result recording. The crossmatch will 
detect the recipient antibodies directed against antigens on the donor red blood cells. The mixture 
of erythrocytes and serum are observed for hemolysis or microscopically for agglutination. Any 
evidence of hemolysis/agglutination indicates an incompatible cross-match. Negative results are 
taken to indicate compatibility. 
 
Conclusions 
Canine blood transfusions are lifesaving interventions that have taken on an essential role 
in veterinary patient management. Pre-transfusion testing of the recipient, including blood typing 
and crossmatching, should be performed with the ultimate objective of preventing an immune- 
mediated transfusion reaction. 
Optimizing patient safety in transfusion medicine is multifaceted and fatal consequences 
can occur if steps are omitted. Pre-transfusion testing is just one aspect to ensure the safety of a 
transfusion. The purpose of blood typing and crossmatching is to prevent incompatible RBC 
transfusions that could lead to potentially fatal immune-mediated transfusion reactions. Mandatory 
performance of pre-transfusion testing for all RBC-containing blood components will improve 
patient safety when transfusions are part of the canine patient management. Today, point-of-care 
pre-transfusion testing is readily available for dogs. As such, pre-transfusion testing is no longer 
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